focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Di&g Regulatory News (ADIG)

Share Price Information for Abrdn Di&g (ADIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 81.20
Bid: 80.20
Ask: 81.20
Change: 0.00 (0.00%)
Spread: 1.00 (1.247%)
Open: 81.20
High: 0.00
Low: 0.00
Prev. Close: 81.20
ADIG Live PriceLast checked at -
Aberdeen Diversified Income & Growth is an Investment Trust

To target a total portfolio return of LIBOR (London Interbank Offered Rate) plus 5.5% p.a. (net of fees) over rolling five-year periods through investments from the widest range of asset classes.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Redemption of 6.25% Bonds due 2031

10 Apr 2024 07:00

RNS Number : 9100J
abrdn Diversified Income and Growth
10 April 2024
 

abrDn diversified income and growth PLC

Legal Entity Identifier (LEI): 2138003QINEGCHYGW702

10 APRIL 2024

REDEMPTION AND CANCELLATION OF 6.25 PER CENT BONDS DUE 2031

Bond Redemption

The Board of abrdn Diversified Income and Growth plc (the "Company") hereby announces that, following the agreement of shareholders to the proposal to put the Company into managed wind-down, the Company redeemed and cancelled the remaining £16,096,000 in aggregate principal amount of its 6.25% Bonds due 2031 (ISIN XS0134340180) (the "Bonds") on 9 April 2024.

As announced on 8 March 2024, the redemption price was 114.983%. The redemption price having been calculated in accordance with the conditions, using the gross redemption yield of the United Kingdom 6% Treasury Stock due 7 December 2028.

Application has been made for the admission of £16,096,000 in principal amount of the Bonds to the Official List of the United Kingdom Listing Authority to be cancelled in accordance with the FCA's Listing Rules. Following this redemption and cancellation there remain no further Bonds outstanding and the Company has no further debt.

 

Expected circular and approvals

 

The Company has commenced the process required for Court approval for the shareholder approved reduction in the nominal value of the Company's ordinary shares from 25 pence per ordinary share to one penny per ordinary share (the "Capital Reduction") and cancellation of the entire amount standing to the credit of the Company's capital redemption reserve (the "Capital Redemption Cancellation") and share premium account to create distributable reserves which may be applied in any manner permitted by the Companies Act and/or the Company's articles of association (including for any bonus share issues and/or redemptions, tender offers, share buy backs and/or other returns of capital) excluding (in respect of the Capital Reduction and Capital Redemption Cancellation) the payment of dividends.

 

The Company also expects in the coming weeks to issue a further circular providing details of the expected initial capital return, which is proposed to be carried out by way of an issue and redemption of bonus shares to all shareholders (the "B Share Scheme"), including a summary of the UK taxation consequences for shareholders. The circular will convene a general meeting to seek the further shareholder approvals required to be granted for the implementation of the B Share Scheme. Subject to these further shareholder approvals being granted and the required Court approvals being received, it is expected that the initial return of capital will be implemented around the end of June 2024.

 

 

Contact details

For further information please contact:

abrdn Holdings Limited, Secretaries

Email: cef.cosec@abrdn.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSMFIUELSESL
Date   Source Headline
22nd Aug 202311:42 amRNSNet Asset Value(s)
21st Aug 20231:38 pmRNSGearing disclosure
21st Aug 202312:56 pmRNSNet Asset Value(s)
18th Aug 20231:08 pmRNSNet Asset Value(s)
17th Aug 20231:03 pmRNSNet Asset Value(s)
16th Aug 202311:30 amRNSNet Asset Value(s)
15th Aug 202311:16 amRNSNet Asset Value(s)
14th Aug 20233:14 pmRNSGearing disclosure
14th Aug 202312:23 pmRNSNet Asset Value(s)
11th Aug 202312:51 pmRNSNet Asset Value(s)
10th Aug 20234:40 pmRNSPortfolio Disclosures
10th Aug 20231:25 pmRNSNet Asset Value(s)
9th Aug 20231:20 pmRNSNet Asset Value(s)
8th Aug 202311:54 amRNSNet Asset Value(s)
7th Aug 20232:52 pmRNSGearing Disclosures
7th Aug 202312:53 pmRNSNet Asset Value(s)
4th Aug 20234:24 pmRNSMonth End Net Asset Value(s)
4th Aug 202312:00 pmRNSNet Asset Value(s)
3rd Aug 20231:50 pmRNSNet Asset Value(s)
2nd Aug 202312:41 pmRNSNet Asset Value(s)
31st Jul 20234:44 pmRNSGearing disclosure
31st Jul 202312:39 pmRNSNet Asset Value(s)
28th Jul 20233:15 pmRNSNet Asset Value(s)
27th Jul 202311:50 amRNSNet Asset Value(s)
26th Jul 202311:31 amRNSNet Asset Value(s)
25th Jul 202311:44 amRNSNet Asset Value(s)
25th Jul 20237:00 amRNSUpdate on Strategic Review
24th Jul 20232:50 pmRNSGearing disclosure
24th Jul 202311:31 amRNSNet Asset Value(s)
21st Jul 202311:42 amRNSNet Asset Value(s)
20th Jul 202312:37 pmRNSNet Asset Value(s)
19th Jul 202312:13 pmRNSNet Asset Value(s)
18th Jul 202311:44 amRNSNet Asset Value(s)
17th Jul 20234:19 pmRNSDirector/PDMR Shareholding
17th Jul 20231:14 pmRNSGearing disclosure
17th Jul 202312:01 pmRNSNet Asset Value(s)
14th Jul 20234:58 pmRNSPortfolio Disclosures
14th Jul 202312:21 pmRNSNet Asset Value(s)
14th Jul 20239:51 amRNSNet Asset Value(s)
12th Jul 202312:25 pmRNSNet Asset Value(s)
11th Jul 202312:47 pmRNSNet Asset Value(s)
10th Jul 20234:54 pmRNSGearing disclosure
10th Jul 202312:48 pmRNSNet Asset Value(s)
7th Jul 20233:56 pmRNSDirector/PDMR Shareholding
7th Jul 202312:59 pmRNSNet Asset Value(s)
6th Jul 20233:50 pmRNSMonth End Net Asset Value(s)
6th Jul 202312:34 pmRNSNet Asset Value(s)
5th Jul 202312:37 pmRNSNet Asset Value(s)
5th Jul 202312:09 pmRNSQuarterly disclosure
4th Jul 20234:51 pmRNSGearing disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.